Main Industry
Biotechnology
Main Product/Service
1. Oral Stem Cell Storage Services and Applications
2. Umbilical Cord and Placental Mesenchymal Stem Cell Storage Services and Applications
3. Clinical Applications of Various Immune Cells
2. Umbilical Cord and Placental Mesenchymal Stem Cell Storage Services and Applications
3. Clinical Applications of Various Immune Cells
The content above was translated by Ai
Founded Year
2019
Unified Business No.
85131480
Status
Active
Number of Employees
8
Total Paid-in
Capital
130,000,000 (NT$)
Location of Company
Taiwan
, Taipei City
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Yuan Cell signed an alliance agreement with Tri-Service General Hospital in 2020 to jointly build a regenerative medicine industry chain. Yuan Cell constructed the "Cell Therapy and Regenerative Medicine Center" on the 11th floor of the Chieh-Shou Building at the Tingzhou Branch of Tri-Service General Hospital, with its primary services focusing on cell therapy medical service items approved under the "Regulations Governing Specific Medical Techniques" (特管法). Meanwhile, the "Cell Therapy and R&D Translational Center" currently being planned and constructed by Yuan Cell on the 10th floor focuses on core objectives such as new drug R&D, cell preparation R&D, and Phase I and II clinical trial research; it is also equipped with multiple GTP laboratories, a national-level cell cryopreservation bank, and other spaces, which are available for lease and occupancy.
The content above was translated by Ai
